Last reviewed · How we verify

NCT03479879

Estradiol Pretreatment With Misoprostol in Second Trimester Miscarriage

Completed Phase 2, PHASE3 Last updated 29 January 2019
What this trial tests

Phase 2, PHASE3 trial testing Estradiol in Miscarriage in 200 participants. Completed in 20 December 2018.

Timeline
21 March 2018
Primary endpoint
20 December 2018
20 December 2018

Quick facts

Lead sponsorAin Shams University
PhasePhase 2, PHASE3
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment200
Start date21 March 2018
Primary completion20 December 2018
Estimated completion20 December 2018
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

Adults 18 to 40, female only, with Miscarriage. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare the effectiveness of estradiol pretreatment with misoprostol and vaginal misoprostol alone in induction of second trimestr miscarriage.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Estradiol

Trials testing the same drug.

Other recruiting trials for Miscarriage

Currently open trials in the same condition.

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03479879.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing